7.54

6.05% 0.43

After Hours: 7.56 0.02 +0.27%

Niagen Bioscience Inc (NAGE)

Overview News Price History Discussions Forecast

Niagen Bioscience Inc stock is traded at $7.54, with a volume of 1.02M. It is up +6.05% in the last 24 hours and down -19.19% over the past month. Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

Previous Close:

$7.11

Open:

$7.11

24h Volume:

1.02M

Relative Volume:

0.95

Market Cap:

$601.34M

Revenue:

$116.30M

Net Income/Loss:

$17.73M

P/E Ratio:

35.90

EPS:

0.21

Net Cash Flow:

$20.88M

1W Performance:

-0.40%

1M Performance:

-19.19%

6M Performance:

-3.95%

1Y Performance:

+0.00%

1-Day Range:

$7.0301

$7.55

1-Week Range:

$7.0301

$7.70

52-Week Range:

$5.33

$14.69

Niagen Bioscience Inc Stock (NAGE) Company Profile

Name

Niagen Bioscience Inc

Sector

Healthcare (1135)

Industry

Biotechnology (635)

Phone

310-388-6706

Address

10900 WILSHIRE BLVD, LOS ANGELES

Employee

104

Twitter

Next Earnings Date

Latest SEC Filings

NAGE's Discussions on Twitter

Compare NAGE with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
NAGE Niagen Bioscience Inc	7.54	567.04M	116.30M	17.73M	20.88M	0.21
VRTX Vertex Pharmaceuticals Inc	425.57	107.66B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	651.80	68.74B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	456.04	58.93B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	818.50	50.51B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	189.60	41.29B	447.02M	-1.18B	-868.57M	-6.1812

Niagen Bioscience Inc Stock (NAGE) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-27-25	Initiated	Canaccord Genuity	Buy
Aug-16-22	Downgrade	Oppenheimer	Outperform → Perform
Aug-11-22	Downgrade	B. Riley Securities	Buy → Neutral
Mar-08-22	Initiated	ROTH Capital	Buy
Oct-16-19	Initiated	Oppenheimer	Outperform
Feb-14-19	Initiated	B. Riley FBR	Buy
Nov-27-17	Resumed	H.C. Wainwright	Buy
Sep-25-17	Initiated	Ladenburg Thalmann	Buy
Jan-03-17	Initiated	Rodman & Renshaw	Buy

View All

Niagen Bioscience Inc Stock (NAGE) Latest News

Nov 02, 2025

Will Niagen Bioscience Inc. (OCD1) stock outperform value peersMarket Growth Report & Safe Swing Trade Setups - newser.com

Nov 02, 2025

Combining machine learning predictions for Niagen Bioscience Inc.Market Performance Summary & Fast Exit and Entry Trade Guides - newser.com

Nov 02, 2025

Is Niagen Bioscience Inc. stock undervalued vs historical averagesJuly 2025 Price Swings & AI Powered Market Trend Analysis - newser.com

Nov 02, 2025

Nov 01, 2025

Leading vs lagging indicators on Niagen Bioscience Inc. performanceJuly 2025 Breakouts & AI Based Trade Execution Alerts - newser.com

Nov 01, 2025

Published on: 2025-11-01 05:58:42 - newser.com

Nov 01, 2025

How Niagen Bioscience Inc. (OCD1) stock reacts to Fed tighteningJuly 2025 Short Interest & Fast Moving Stock Watchlists - newser.com

Nov 01, 2025

Oct 31, 2025

Using data filters to optimize entry into Niagen Bioscience Inc.Earnings Overview Report & Capital Efficiency Focused Strategies - newser.com

Oct 31, 2025

Niagen Bioscience Inc expected to post earnings of 2 cents a shareEarnings Preview - TradingView

Oct 31, 2025

Published on: 2025-10-31 04:25:46 - newser.com

Oct 31, 2025

Using Ichimoku Cloud for Niagen Bioscience Inc. technicalsPortfolio Update Report & Weekly Breakout Opportunity Watchlist - newser.com

Oct 31, 2025

Measuring Niagen Bioscience Inc.’s beta against major indicesJuly 2025 Decliners & Community Consensus Picks - newser.com

Oct 31, 2025

Why Niagen Bioscience Inc. stock is in analyst buy zoneTrade Risk Report & Long-Term Safe Return Strategies - newser.com

Oct 31, 2025

Oct 29, 2025